MEDX Among Health Care ETFs
End-of-day Nov 12, 2026 · 33 Health care ETFs by YTD
Loading…
Getting the latest data.
Horizon KineticsSectorsHealth Care#110 of 263 by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.8% | +0.9% | +7.1% | +6.1% | +14.1% | +17.7% | +44.4% | — | +33.0% |
| Peer average | −1.7% | +1.7% | +5.8% | +4.3% | +21.7% | +26.7% | +69.8% | +26.0% | — |
| S&P 500 · VOO | −0.3% | +3.3% | −1.6% | −2.2% | +11.9% | +12.1% | +80.1% | +73.9% | — |
$213 of every $1,000 in MEDX is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly | Healthcare | 21.28% | $2,127.87 | 2,654 | $3.8M |
| 2 | ABBVAbbVie | Healthcare | 9.98% | $998.48 | 6,068 | $1.8M |
| 3 | —US Bank Mmda - Usbgfs 7 06/01/2031 | — | 7.64% | $764.03 | 1.4M | $1.4M |
| 4 | NVSNovartis AG | Healthcare | 6.78% | $678.07 | 7,582 | $1.2M |
| 5 | JNJJohnson & Johnson | Healthcare | 5.94% | $594.09 | 3,798 | $1.1M |
| 6 | AMGNAmgen | Healthcare | 4.87% | $486.74 | 1,864 | $873K |
| 7 | ALKSAlkermes | Healthcare | 4.86% | $486.15 | 18K | $872K |
| 8 | AZNAstraZeneca | Healthcare | 4.69% | $469.01 | 4,533 | $841K |
| 9 | MRKMerck | Healthcare | 4.36% | $435.79 | 5,308 | $781K |
| 10 | BMYBristol-Myers Squibb | Healthcare | 4.19% | $418.87 | 12K | $751K |
| 11 | BIIBBiogen | Healthcare | 3.48% | $348.30 | 2,464 | $624K |
| 12 | PFEPfizer | Healthcare | 3.36% | $336.31 | 20K | $603K |
| 13 | REGNRegeneron Pharmaceuticals | Healthcare | 3.05% | $305.06 | 570 | $547K |
| 14 | GSKGSK | Healthcare | 2.51% | $251.21 | 8,900 | $450K |
| 15 | CRSPCRISPR Therapeutics AG | Healthcare | 2.13% | $212.89 | 8,342 | $382K |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 21.28% |
| 2 | ABBV | AbbVie | 9.98% |
| 3 | NVS | Novartis AG | 6.78% |
| 4 | JNJ | Johnson & Johnson | 5.94% |
| 5 | AMGN | Amgen | 4.87% |
| 6 | ALKS | Alkermes | 4.86% |
| 7 | AZN | AstraZeneca | 4.69% |
| 8 | MRK | Merck & | 4.36% |
| 9 | BMY | Bristol-Myers Squibb | 4.19% |
| 10 | BIIB | Biogen | 3.48% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 23, 2025 | Dec 24, 2025 | $0.41 |
| Dec 24, 2024 | Dec 26, 2024 | $0.51 |
| Dec 27, 2023 | Dec 29, 2023 | $1.64 |